What is ALS?

ALS (also known as Lou Gehrig's Disease) is a progressive neuromuscular disease in which nerve cells die and leave voluntary muscles paralyzed.
Every day two or three Canadians die of the disease.

Learn more about ALS »


ALS Society of Alberta

Request for Volunteers!

Request for Volunteers!

2015 Calgary International Auto & Truck Show – Ticket Taker Volunteers

March 11-15, 2015

The ALS Society of Alberta is partnering with the Calgary Motor Dealers Association to provide volunteers for the Calgary International Auto & Truck Show March 11 - March 15, 2015 to take tickets at the door.  The ALS Society will benefit greatly by helping the CMDA with their event! Therefore, we are looking for volunteers to help from the ALS Society and we hope you are available to support this opportunity!

We have only filled 44% of our volunteer spots, so we need your help! If this opportunity interests you, you can sign up as follows:

  1. Click this link to go to our invitation page on VolunteerSpot: http://vols.pt/ee74zm
  2. Enter your email address: (You will NOT need to register an account on VolunteerSpot)
  3. Sign up! Choose your spots - VolunteerSpot will send you an automated confirmation and reminders. Easy!

Alternatively, or if you have any questions regarding this event, please contact Diane at 403-228-3857 or This e-mail address is being protected from spambots. You need JavaScript enabled to view it


Exciting Announcement!


The ALS Society of Alberta is delighted to announce a wonderful new partnership! Mikael Backlund of the Calgary Flames has chosen the ALS Society of Alberta as one of his charities of choice!

Read more: Exciting Announcement!


Ice Bucket Challenge Funds New Clinical Trial

We are proud to announce funding for a new clinical trial from your donations through the ALS Ice Bucket Challenge and ALS Canada's partnership with Brain Canada and the Government of Canada!

The Arthur J. Hudson Translational Team Grant was first announced on May 3, 2014 at the ALS Canada Research Forum and the inaugural competition deadline was July 1, 2014. This new grant program is designed to fund teams of Canadian researchers to accelerate the movement of ideas out of the laboratory and into the clinic with the hope of assisting development of new therapeutics for ALS. It is the cornerstone of our ALS Canada Research Program designed to emphasize bench-to-bedside translation. For the first time ever, ALS Canada, in partnership with Brain Canada, have utilized an International Peer Review Panel consisting of seven European and American ALS experts, spanning the basic to clinical spectrum, who convened in Toronto in November to determine the top project amongst strong competition.

It is a great pleasure to announce that the recipient of the first Arthur J. Hudson Translational Team Grant is a team led by Dr. Lawrence Korngut, MD at the University of Calgary and also includes Dr. Lorne Zinman, MD from Sunnybrook Health Sciences Centre and University of Toronto. Together, they will pursue “A randomized controlled trial of pimozide in subjects with ALS”; a Phase II study involving 100 participants across 8 ALS clinics across Canada.

This trial, led by the Principal Investigator of the Canadian Neuromuscular Disease Registry (CNDR) and the Chair of the Canadian ALS Research Network (CALS) will examine whether pimozide, a drug already approved by Health Canada for use in psychoses like schizophrenia and Tourette’s syndrome, might slow progression of ALS. Pimozide is particularly effective at stabilizing neuromuscular function, which means it can strengthen the connection where the motor neuron meets the muscle (called the neuromuscular junction or NMJ). It is hoped that by strengthening this connection, there will be preservation of transmission of signals from the brain to the muscle and slowing of paralysis in ALS.

Read more: Ice Bucket Challenge Funds New Clinical Trial


ALS Societies across Canada announce the fund allocation from the Ice Bucket Challenge

The ALS Society of Alberta is excited to announce that the ALS Ice Bucket Challenge has raised $16.2 million in Canada due to the generosity of more than 260,000 Canadians. This record-breaking success has allowed for ALS to become a commonly known disease, and has given hope to the ALS community. Funds will be allocated toward the national ALS research program, and to client support services within each province.

ALS Societies will invest $10 million in ALS research and $6 million in programs that deliver critical support to Canadians living with ALS.

Read more: ALS Societies across Canada announce the fund allocation from the Ice Bucket Challenge


#IceBucketChallenge for ALS

bucket full of thanks banner

Thank you to everyone who has participated in the #IceBucketChallenge!
We are overwhelmed at the amount of awareness and fundraising support we have received!

Read more: #IceBucketChallenge for ALS


Social Networking


Keep up-to-date on the latest news at the ALS society of Alberta by subscribing to our eNews.

Receive HTML?



ALS Society of Alberta
#250, 4723 - 1 Street SW Calgary,
AB Canada T2G 4Y8

Phone: 1(403)228-3857  
Fax: 1(403)228-7752  
Toll-Free: 1(888)309-1111  
E-mail: info@alsab.ca